AI Article Synopsis

  • Conflicting literature exists regarding whether non-dense adipose tissue in the breast acts as a risk or protective factor for breast cancer, with various biological hypotheses presented.
  • Limitations in study design and statistical methods may explain these inconsistent results, prompting a need for improved analysis techniques.
  • In a large Swedish cohort study, the authors found little evidence linking non-dense tissue to breast cancer risk, suggesting that previous studies may have struggled to isolate the effects of non-dense tissue or relied on potentially flawed modeling assumptions.

Article Abstract

Conflicting results have appeared in the literature on whether the amount of non-dense, adipose tissue in the breast is a risk factor or a protective factor for breast cancer, and biological hypotheses supporting both have been proposed. We suggest here that limitations in study design and statistical methodology could potentially explain the inconsistent results. Specifically, we exploit recent advances in methodology and software developed for the joint analysis of multiple longitudinal outcomes and time-to-event data to jointly analyze dense and non-dense tissue trajectories and the risk of breast cancer in a large, Swedish, screening cohort. We also perform extensive sensitivity analyses by mimicking analyses/designs of previously published studies, e.g. ignoring available longitudinal data. Overall, we did not find strong evidence supporting an association between non-dense tissue and the risk of incident breast cancer. We hypothesize that (1) previous studies have not been able to isolate the effect of non-dense tissue from dense tissue or adipose tissue elsewhere in the body, that (2) estimates of the effect of non-dense tissue on risk are strongly sensitive to modeling assumptions, or that (3) the effect size of non-dense tissue on breast cancer risk is likely to be small/not clinically relevant.

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kwae196DOI Listing

Publication Analysis

Top Keywords

breast cancer
20
non-dense tissue
20
tissue breast
12
tissue
9
cancer risk
8
adipose tissue
8
tissue risk
8
non-dense
7
breast
7
risk
6

Similar Publications

Aims: This study aims to identify and evaluate promising therapeutic proteins and compounds for breast cancer treatment through a comprehensive database search and molecular docking analysis.

Background: Breast cancer (BC), primarily originating from the terminal ductal-lobular unit of the breast, is the most prevalent form of cancer globally. In 2020, an estimated 2.

View Article and Find Full Text PDF

Leveraging Optical Anisotropy of the Morpho Butterfly Wing for Quantitative, Stain-Free, and Contact-Free Assessment of Biological Tissue Microstructures.

Adv Mater

January 2025

Department of Mechanical and Aerospace Engineering, Program of Materials Science and Engineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.

Changes in the density and organization of fibrous biological tissues often accompany the progression of serious diseases ranging from fibrosis to neurodegenerative diseases, heart disease and cancer. However, challenges in cost, complexity, or precision faced by existing imaging methodologies and materials pose barriers to elucidating the role of tissue microstructure in disease. Here, we leverage the intrinsic optical anisotropy of the Morpho butterfly wing and introduce Morpho-Enhanced Polarized Light Microscopy (MorE-PoL), a stain- and contact-free imaging platform that enhances and quantifies the birefringent material properties of fibrous biological tissues.

View Article and Find Full Text PDF

Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review.

J Pharm Policy Pract

January 2025

Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia.

Background: Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect and summarise articles exploring the QoL of patients undergoing oncology treatments in KSA.

View Article and Find Full Text PDF

Cell-membrane targeting sonodynamic therapy combination with FSP1 inhibition for ferroptosis-boosted immunotherapy.

Mater Today Bio

February 2025

Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, PR China.

Cell membrane targeting sonodynamic therapy could induce the accumulation of lipid peroxidation (LPO), drive ferroptosis, and further enhances immunogenic cell death (ICD) effects. However, ferroptosis is restrained by the ferroptosis suppressor protein 1 (FSP1) at the plasma membrane, which can catalyze the regeneration of ubiquinone (CoQ10) by using NAD(P)H to suppress the LPO accumulation. This work describes the construction of US-active nanoparticles (TiF NPs), which combinate cell-membrane targeting sonosensitizer TBT-CQi with FSP1 inhibitor (iFSP1), facilitating cell-membrane targeting sonodynamic-triggered ferroptosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!